Somatic mutations of the KEAP1 gene in common solid cancers

Histopathology
Nam Jin YooSug Hyung Lee

Abstract

KEAP1 inhibits nuclear factor erythroid 2-related factor 2 (NRF2)-induced cytoprotection, and is considered to be a candidate tumour suppressor. Somatic mutation of NRF2 has been analysed in a wide variety of human cancers, whereas somatic mutation of KEAP1 has been reported only in lung and gall bladder cancers. The aim of our study was to investigate whether KEAP1 mutations are widespread in human cancers. We analysed 499 cancer tissues from lung, breast, colon, stomach, liver, larynx and prostate, and leukaemias, by single-strand conformation polymorphism analysis. We detected somatic mutations of KEAP1 in gastric (11.1%), hepatocellular (8.9%), colorectal (7.8%), lung (4.6%), breast (2.0%) and prostate (1.3%) carcinomas. Allelic losses of the KEAP1 locus were identified in 42.9% of cancers with KEAP1 mutations, but no NRF2 mutations were detected in these cancers. The NRF2-activated cytoprotective proteins (NAD(P)H dehydrogenase quinone 1 and glutamine-cysteine ligase catalytic subunit) were expressed in all of the cancers with KEAP1 mutations. Our data show that KEAP1 mutations occur widely in solid cancers, irrespective of histological type. Biallelic inactivation of KEAP1 and increased levels of cytoprotective proteins i...Continue Reading

References

Oct 31, 2001·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Y KatohM Yamamoto
Oct 1, 2003·Nature Genetics·Nobunao WakabayashiMasayuki Yamamoto
Dec 2, 2004·Molecular and Cellular Biology·Donna D ZhangMark Hannink
Jun 1, 2005·Molecular and Cellular Biology·Antje BanningRegina Brigelius-Flohé
Dec 16, 2005·Molecular and Cellular Biology·Akira KobayashiMasayuki Yamamoto
Mar 2, 2006·Molecular Cell·Balasundaram PadmanabhanMasayuki Yamamoto
Jun 15, 2006·Antioxidants & Redox Signaling·Hiroshi Kasai, Kazuaki Kawai
Sep 9, 2006·Science·Tobias SjöblomVictor E Velculescu
Oct 6, 2006·PLoS Medicine·Anju SinghShyam Biswal
Dec 6, 2006·Drug Metabolism Reviews·Donna D Zhang
Sep 8, 2007·Biochemical and Biophysical Research Communications·Paul Nioi, Truyen Nguyen
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Tatsuhiro ShibataSetsuo Hirohashi
Oct 8, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alexandria LauDonna D Zhang
Aug 12, 2009·Free Radical Biology & Medicine·James W KasparAnil K Jaiswal
Dec 8, 2009·The Journal of Pathology·Yoo Ri KimSug Hyung Lee
Mar 10, 2010·Journal of Surgical Oncology·Tsuyoshi TakahashiHiromi Wada

❮ Previous
Next ❯

Citations

Jul 20, 2012·Nature Reviews. Cancer·Michael B Sporn, Karen T Liby
Mar 19, 2013·Journal of Proteomics·Ioannis P TrougakosVassilis G Gorgoulis
Nov 26, 2013·Pathology Oncology Research : POR·Youn Jin ChoiSug Hyung Lee
Jul 23, 2014·Current Opinion in Pharmacology·Sarah J Ross, Susan E Critchlow
Aug 13, 2013·Oxidative Medicine and Cellular Longevity·Hye-Youn Cho
Nov 10, 2013·Journal of Gastroenterology·Takayuki ShimizuKeiichi Kubota
Feb 18, 2016·Hematological Oncology·Hye Rim OhSug Hyung Lee
Feb 5, 2015·Scandinavian Journal of Gastroenterology·Mi Ryoung ChoiSug Hyung Lee
Dec 5, 2015·Scandinavian Journal of Gastroenterology·Yun Sol JoSug Hyung Lee
Feb 2, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Brittany C LipchickMikhail A Nikiforov
Jun 29, 2015·Free Radical Biology & Medicine·Hye-Youn ChoSteven R Kleeberger
Aug 4, 2012·Trends in Endocrinology and Metabolism : TEM·Andrew R Mullen, Ralph J DeBerardinis
Oct 23, 2014·Journal of Cancer Prevention·Jae Hong NoYong Sang Song
Aug 12, 2015·Pathology Oncology Research : POR·Hye Rim OhSug Hyung Lee
Sep 4, 2015·Biological & Pharmaceutical Bulletin·Toshiyuki MatsunagaAkira Ikari
Aug 27, 2015·Pathology Oncology Research : POR·Mi Ryoung ChoiSug Hyung Lee
Nov 1, 2015·Pathology Oncology Research : POR·Yun Sol JoSug Hyung Lee
Aug 20, 2014·Journal of Hepatology·Melanie EichenmüllerRoland Kappler
Sep 27, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mi Ryoung ChoiSug Hyung Lee
Jul 15, 2015·Pathology Oncology Research : POR·Yun Sol JoNam Jin Yoo
Nov 10, 2013·Free Radical Biology & Medicine·Hye-Kyung Na, Young-Joon Surh
Jan 1, 2013·Free Radical Biology & Medicine·Suryakant K Niture, Anil K Jaiswal
Oct 30, 2014·Pathology Oncology Research : POR·Youn Jin ChoiSug Hyung Lee
Jan 31, 2015·Pathology Oncology Research : POR·Mi Ryoung ChoiChang Hyeok An
Jun 11, 2014·Pathology Oncology Research : POR·Sung Hak LeeSug Hyung Lee
Feb 2, 2015·Pathology Oncology Research : POR·Youn Jin ChoiSug Hyung Lee
Dec 20, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Raffaela BarbanoPaola Parrella
Jul 4, 2013·Free Radical Biology & Medicine·Irene Gañán-GómezGuillermo García-Manero
Nov 19, 2014·Annals of Hematology·Sun Yong HwangSug Hyung Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.